At present, the human Factor H protein family represents seven multidomain, multifunctional serum proteins. This group includes the complement and immune regulators Factor H, the Factor H-like protein 1 (FHL-1) and five Factor H-related proteins proteins (FHR-1, -2, -3, -4 and -5). Each is exclusively composed of individually folded protein domains, termed short consensus repeats (SCRs) or complement control modules. Structure-function analyses allowed the localization of the complement regulatory domain of Factor H and FHL-1 in the N-terminal region within SCRs 1-4. In addition, multiple binding sites for C3b, heparin and microbial surface proteins were localized in the N-terminus, within the middle region and also in the C-terminus of Factor H and FHL-1. Recent results show a central role for the C-terminus of Factor H, i.e. SCRs 19-20. These particular domains are con-
served in all FHRs identified so far, include contact points for C3b, heparin and microbial surface proteins and represent a 'hot-spot' for gene mutations in patients that suffer from the Factor H-associated form of haemolytic uraemic syndrome.
The human Factor H protein family
Seven structurally and immunologically related members of the human Factor H protein family have been identified to date (Figure 1 ). T h e multifunctional 150-kDa Factor H plasma protein, a central effector of innate immunity, is the best characterized member of this group. This protein plays an important role in the regulation of complement activation and possesses antiinflammatory activities. The Factor H-like protein 1 (FHL-1 or reconectin), which is derived from the human Factor H gene by means of alternative splicing, displays very similar complementregulatory activities. T h e precise function of the five Factor H-related proteins (FHR-1, -2, -3, -4 and -5) is currently under investigation. All proteins of the Factor H protein family are predominately synthesized in the liver and the secreted proteins are composed exclusively of globular protein domains termed short consensus repeats (SCRs). Although the members of this group differ in the number of SCRs, the individual SCR domains display a high degree of identity to each other, thus explaining the immunological cross-reactivity of the individual proteins.
T h e high degree of structural conservation of exon. T h e FHL-1 and Factor H transcripts individual domains suggests conserved and cominitiate at the same start site and are regulated by mon functions of the members of this protein the same gene promoter. However, the FHL-1 family.
transcript is spliced to a unique exon, which T h e genes for human Factor H and the other encodes the four C-terminal amino acids of the known members of the Factor H family are located protein, a stop codon and a unique untranslated 3' within the regulators of complement activation (RCAs) gene cluster on chromosome lq32 [l] . T h e transcript representing FHL-1 is processed from the Factor H gene by means of alternative splicing [2, 3] . T h e five FHRs are encoded by distinct genes, which are all located in the RCA gene cluster in the vicinity of the gene coding for the blood-clotting factor F X I I I b [1,&6] . T h e genomic structure of a polymorphic form of the human FHR-2 gene has been elucidated and, as is the case with other genes that contain SCRs, each structural SCR domain is encoded by a unique end [3] .
Factor H , which is composed of 20 SCR domains, is the central soluble activation inhibitor of the alternative complement pathway. T h e protein prevents binding of Factor B to C3b, supports the dissociation of the C3bBb complex (decayaccelerating activity) and acts as a cofactor for the cleavage of C3b by Factor I FHL-1, which is identical with the seven N-terminal SCRs of Factor H and includes an extension of four amino acids at its C-terminal end, acts as a complement regulator and displays cofactor and decay-accelerating activity [lo] . In addition, FHL-1 has unique functions: it acts as an adhesion protein, and this function is mediated by the R G D domain located within SCR 4 [ l l ] . Factor H , as a rather 'sticky' protein, binds to and
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The human Factor H protein family plasma at a concentration of approx. 500 pg/ml, the plasma concentration of FHL-1 is only approx. 10-50 pglml. FHR-1 is composed of five SCR domains. This human plasma protein exists in two forms that differ by the number of attached carbohydrate residues [2] . T h e 37-kDa (FHR-la) form has one and the 43-kDa form (FHR-ID) has two carbohydrate side-chains attached [13] . FHR-2 is composed of four SCRs and is present in human plasma in both a non-glycosylated 24-kDa form (FHR-2) and a glycosylated 29-kDa form (FHR2a) [14] . T h e functions of FHR-1 and FHR-2 are, to date, poorly defined. Both proteins are major constituents of specific lipoprotein particles which are composed of apoA-I, lipopolysaccharidebinding protein and other unidentified polypeptides and which facilitate the adhesive response of neutrophils to lipopolysaccharide [15] . A comparison indicates two areas of substantial identity to the region of SCRs 6-10, as well as to the Cterminal SCRs of Factor H. FHR-3 and FHR-4 are composed of five SCRs that show identity with each other, to the middle region and to the Cterminal region of Factor H [ 16,171. T h e aminoacid sequence of FHR-3 includes five potential N-linked glycosylation sites. Several glycosylated forms of the protein exist in human plasma, which range in molecular mass from 35 to 56 kDa [18] . Functional analyses show that FHR-3 binds to C3b and to heparin [18] . FHR-4 exists in human plasma solely in a dimeric, glycosylated 86-kDa form [17] . FHR-5, which also binds C3b, is organized into nine SCR domains which show identity to Factor H and other FHRs [19] .
Sequence comparisons reveal two conserved regions among members of the Factor H family, which in Factor H are located in SCRs 6-10 and in the SCRs nearest the C-terminus (19 and 20) (Figure 1 ). Although the function of the FHRs is under investigation at present, the available results suggest common or even identical functions for some proteins that bind to C3b and heparin together with the great degree of similarity of individual domains and the structural conservation.
Structure-function studies: localization of functional domains
T h e organization into multiple, individually folded protein domains makes Factor H (and the other members of this family) ideal candidates for structurefunction analyses. The use of recombinant deletion mutants allowed the localization of functional protein domains and the identification of multiple binding sites. In summary, these studies show that members of the Factor H protein family represent multifunctional, multidomain proteins. The complement regulatory domains of Binding of Factor H to polyanions is presumed to contribute substantially to the discrimination between activator and non-activator surfaces. A total of three separate binding regions for heparin have been identified within the protein [24-271: one domain is located within SCR 7 and is shared between Factor H and FHL-1 and one additional region is located within SCR 20 of the recombinant expressed Factor H protein [28] .
T h e use of tryptic fragments derived from purified Factor H in combination with reducing SDS/ PAGE analysis showed the presence of an additional heparin-binding site in or near SCR 13 [24] . The FHL-1 protein has a heparin-binding site within the SCR 7.
These analyses indicate a complex interaction of Factor H with its central ligands, C3b and surface glycosaminoglycans. The presence of at least three binding sites for both C3b and heparin suggests simultaneous multiple interaction points of one Factor H protein with each ligand, or a multipoint interaction between several molecules.
C-terminal region in focus
T h e complement regulatory domains of Factor H are located in the N-terminus. Current analysis, however, is focused on the opposite end, the Cterminus. Structural assays and several separate approaches show a crucial and central role of SCRs 19 and 20 for protein function: this domain (i) is highly conserved within the individual members of the Factor H protein family; (ii) includes overlapping heparin-and C3 b-binding domains [26, 29] ; (iii) is the binding domain for microbial surface proteins [30-331; and (iv) represents a hot spot in Factor H-associated haemolytic uraemic syndrome (HUS) [34-361 (Figure 3) . Thus, the Cterminus seems relevant for target recognition and the discrimination between self and non-self structures, and mutations in this domain may affect local anti-inflammatory activity at the exposed endothelial lining [37] .
Interaction with microbes
T h e complement regulators Factor H and FHL-1 control the activity of the alternative pathway of complement both temporally and spatially and, consequently, inhibit the formation of harmful activation products. Host cells use these soluble immune-regulators to control complement activation directly at their surfaces. Pathogenic microorganisms exploit this strategy and express surface proteins which mimic the binding characteristics of host surface proteins and which bind Factor H and/or FHL-1. An increasing number of microbes is currently being identified which use this strategy and acquire the host regulators Factor H and FHL-1. In the case of Borrelia species, the acquisition of the host regulators is directly associated with serum resistance, as the serum-resistant strains of the human pathogenic genospecies Borrelia afielii and Borrelia burgdorferi sensu stricto, but not the serum-sensitive strains of the (CRASP-1, -2, -3, -4 and -5 ) [30, 38] .
[46], Streptococcus pyogenes [28, 32] , Streptococcus
Binding and acquisition of the host regulators pneumoniae [47] and Yersinia enterocolitica [48] . Factor H and FHL-1 has been shown for microbes T h e interacting surface proteins have been identiand pathogens, including B . burgdorferi [31,38- l-
ingly some microbes express up to five distinct proteins at their surface (CRASP-1, -2, -3, -4 and -5) which display different and unique binding properties for host immune-regulators. T h e surface-attached host proteins maintain their regulatory activities and inactivate newly formed C3b (Figure 3) . Thus, by acquisition of host immune regulators directly to their surfaces, microorganisms can evade the destructive effects of this powerful defence system.
Association with diseases
As plasma proteins, Factor H and FHL-1 are soluble regulators that can bind to and protect cells and tissues that lack endogenous membrane regulators. An essential role of Factor H for tissue integrity and inflammation is inferred as the protein is overexpressed in diseases such as rheumatoid arthritis. Mutations in the gene are associated with a wide spectrum of severe diseases including Type I I membranoproliferative glo- 
